application) The primary goal of this Clinical/Tissue Core is to provide tissues and serum from IBD patients to center investigators. The second goal of this core has been to establish a reference database of IBD patients and patient's samples for this center and nationally. This core has developed a customized database that is suitable to document the clinical and laboratory information of the entire IBD population at MGH. Through this database, it is easily to identify the desired patient subgroups and to provide clinical correlation and validation of tissue samples. During the previous funding period, the core service has been expanded to include development of a bank of serum and DNA samples from the IBD patient population. The core will provide the following services for center investigators; 1) clinical database and patient identification. The core will maintain an active clinical database of IBD patients. The investigators with the approved project have access to this database to identify patients needed for study; 2) tissue samples. The core is to provide tissue and serum for center investigator and to establish tissue and serum banks. Investigators needing tissue or serum samples contact the Core director or core technician after the director?s approval; 3) tissue reference bank. In addition to provision of fresh samples of IBD-related tissues and relevant controls, the core has been to store the validated tissue and serum samples for later study; 4) tissue sections. This service has made the core more effective in facilitating the goal of center investigators and make more maximal use of tissue samples; and 5) clinical support and biostatistical analysis. This core will provide the expertise in study design, data base management and analysis for clinical research.

Project Start
2002-01-01
Project End
2002-12-31
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Merkulova, Maria; P?unescu, Teodor G; Nair, Anil V et al. (2018) Targeted deletion of the Ncoa7 gene results in incomplete distal renal tubular acidosis in mice. Am J Physiol Renal Physiol 315:F173-F185
Cushing, Kelly C; Kordbacheh, Hamed; Gee, Michael S et al. (2018) Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. J Crohns Colitis :
Vatanen, Tommi; Plichta, Damian R; Somani, Juhi et al. (2018) Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat Microbiol :
Su, C; Su, L; Li, Y et al. (2018) Helminth-induced alterations of the gut microbiota exacerbate bacterial colitis. Mucosal Immunol 11:144-157
Momozawa, Yukihide; Dmitrieva, Julia; Théâtre, Emilie et al. (2018) IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nat Commun 9:2427
Burke, Kristin E; Khalili, Hamed; Garber, John J et al. (2018) Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis. Inflamm Bowel Dis 24:1840-1848
Martin, Alicia R; Karczewski, Konrad J; Kerminen, Sini et al. (2018) Haplotype Sharing Provides Insights into Fine-Scale Population History and Disease in Finland. Am J Hum Genet 102:760-775
Ganna, Andrea; Satterstrom, F Kyle; Zekavat, Seyedeh M et al. (2018) Quantifying the Impact of Rare and Ultra-rare Coding Variation across the Phenotypic Spectrum. Am J Hum Genet 102:1204-1211
Vandoorne, Katrien; Rohde, David; Kim, Hye-Yeong et al. (2018) Imaging the Vascular Bone Marrow Niche During Inflammatory Stress. Circ Res 123:415-427
Cai, Tianrun; Lin, Tzu-Chieh; Bond, Allison et al. (2018) The Association Between Arthralgia and Vedolizumab Using Natural Language Processing. Inflamm Bowel Dis 24:2242-2246

Showing the most recent 10 out of 1166 publications